Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polyethylene Glycol for ACF Reduction and Biomarker Modulation in Individuals With CRC Risk

NCT00828984 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00828984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00828984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polyethylene Glycol for ACF Reduction and Biomarker Modulation in Individuals With CRC Risk
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
October 31, 2014
Enrollment
87 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adenomatous polyp, colorectal carcinoma